MedTrace Logo

Efficacy Study of a Repairing Cream in Atopic Dermatitis

NCT07742241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2026-08-03

No results posted yet for this study

Summary

The application of DermControl®, a repair cream based on hyaluronic acid, sh-oligopeptide-1 and polyphenols, in combination with topical corticosteroids, could help to improve epidermal barrier function in patients with atopic dermatitis, improving their symptoms and Quality of Life.

Conditions

  • Atopic Dermatitis (AD)

Interventions

DEVICE

Dermcontrol, cream based on hyaluronic acid and sh-oligopeptide-1

Emulgel containing hyaluronic acid, glycerol, grape seed oil, Calendula officinalis, aloe vera and sh-oligopeptide-1

Sponsors & Collaborators

  • Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-09
Primary Completion
2024-04-30
Completion
2025-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07742241 on ClinicalTrials.gov